Rifabutin - Latest Advances

Novel regimens for treatment of Mycobacterium avium lung disease based on advanced in vitro systems and the mathematics of basis functions.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

Single-ascending and multiple-ascending dose study of the pharmacokinetics, safety, and tolerability of BV100 (rifabutin for infusion) in healthy volunteers.

Journal: Antimicrobial agents and chemotherapy

Published: March 02, 2026

Rifamycin-, macrolide-, and ethambutol-free combinations to treat Mycobacterium avium complex lung disease.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: February 27, 2026

Drug-Related Uveitis: A Real-World Study Based on the Food and Drug Administration Adverse Event Reporting System Database.

Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics

Published: February 24, 2026

Rifabutin for Rhodococcus hoagii Pulmonary Abscess in a Cancer Patient on Everolimus.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: February 09, 2026

Concurrent Mold, Mycobacterial, and Viral Infections in a Hematopoietic Stem Cell Transplant Recipient Undergoing Lung Transplantation for Graft-Versus-Host Disease.

Journal: Current oncology (Toronto, Ont.)

Published: January 28, 2026

Design, Synthesis, and Biological Evaluation of Acid-Responsive Bifunctional Molecules with Dual Anti-Helicobacter pylori and Acid Suppression Activities.

Journal: Journal of medicinal chemistry

Published: January 02, 2026

Rifabutin boosts rifampicin accumulation in THP-1-derived M2 macrophages by inhibiting P-glycoprotein efflux activity.

Journal: Archives of toxicology

Published: December 23, 2025

Mycobacterium haemophilum Infection in a Patient With Systemic Lupus Erythematosus and Antisynthetase Syndrome: A Case Report and Literature Review.

Journal: Cureus

Published: December 22, 2025

Genome-guided discovery of tropansamycins: antimicrobial pentaketide ansamycins.

Journal: Engineering microbiology

Published: December 10, 2025

Third-Line and Later Susceptibility-Guided Helicobacter pylori Eradication Therapies: A Multicenter Study of Vonoprazan-Amoxicillin-Sitafloxacin/Rifabutin Regimens.

Journal: Journal of clinical medicine

Published: December 03, 2025

A Hypothesis of Gut-Liver Mediated Heterosis: Multi-Omics Insights into Hybrid Taimen Immunometabolism (Hucho taimen ♀ × Brachymystax lenok ♂).

Journal: Animals : an open access journal from MDPI

Published: November 28, 2025